FREELINE THERAPEUTICS HOLDIN (FRLN) Stock Analyst Ratings

NASDAQ:FRLN • US35655L2060

6.48 USD
0 (0%)
At close: Feb 16, 2024
6.48 USD
0 (0%)
After Hours: 2/16/2024, 8:00:24 PM
Overview Stock Chart Technical Analysis Fundamental Analysis Analyst Ratings Earnings Estimates Financials Ownership News
Buy % Consensus

80

ChartMill assigns a Buy % Consensus number of 80% to FRLN. The Buy consensus is the weighted average rating of the current analysts ratings.

  • Analysts have set a mean price target forecast of 8.42. This target is 29.86% above the current price.
  • FRLN was analyzed by 8 analysts. The buy percentage consensus is at 80. So analysts seem to be have mildly positive about FRLN.
  • In the previous month the buy percentage consensus was at a similar level.
  • FRLN was analyzed by 8 analysts. More opinions would make the average more meaningful.

Related screens

Find peers with buy consensus above 85%
FRLN Historical Analyst RatingsFRLN Historical Analyst Buy, Sell and Hold Ratings and number of analysts.Historical Monthly Analyst Rating -19 -17 -15 -13 -11 -9 -7 -5 -3 -1 2 4 6 8 10

Price Target & Forecast

Price Low Median Mean High 6.486.578.428.4210.50 - 1.31% 29.86% 29.86% 62.04%

Related screens

Find peers 30% below price target
FRLN Current Analyst RatingFRLN Current Analyst Buy, Sell and Hold Ratings.Current Analyst Rating Strong Buy Buy Hold Sell Strong Sell 0 0 0 0 0
Up and Down Grades
Date Firm Action Rating
2023-11-28 HC Wainwright & Co. Downgrade Buy -> Neutral
2023-10-18 Wedbush Downgrade Outperform -> Neutral
2023-08-17 HC Wainwright & Co. Reiterate Buy -> Buy
2023-08-16 Stifel Maintains Hold -> Hold
2023-08-01 HC Wainwright & Co. Reiterate Buy -> Buy
2023-06-01 Stifel Reiterate Hold -> Hold
2023-05-31 HC Wainwright & Co. Reiterate Buy
2023-04-05 Stifel Downgrade Buy -> Hold
2023-04-05 HC Wainwright & Co. Maintains Buy
2022-08-22 HC Wainwright & Co. Maintains Buy
2022-08-11 BTIG Maintains Buy
2022-02-01 Morgan Stanley Downgrade Overweight -> Equal-Weight
2022-01-07 Redburn Partners Upgrade Neutral -> Buy
2021-11-29 BTIG Initiate Buy
2021-08-18 HC Wainwright & Co. Maintains Buy
2021-08-17 JP Morgan Downgrade Overweight -> Neutral
2021-05-19 HC Wainwright & Co. Initiate Buy
2021-05-06 Guggenheim Initiate Buy
2021-04-06 Morgan Stanley Maintains Overweight
2021-03-23 Mizuho Initiate Buy
2021-03-02 Stifel Initiate Buy

FREELINE THERAPEUTICS HOLDIN / FRLN FAQ

What do analysts expect the price target to be for FREELINE THERAPEUTICS HOLDIN (FRLN)?

8 analysts have analysed FRLN and the average price target is 8.41 USD. This implies a price increase of 29.86% is expected in the next year compared to the current price of 6.48.


How do analysts rate FREELINE THERAPEUTICS HOLDIN (FRLN)?

The consensus rating for FREELINE THERAPEUTICS HOLDIN (FRLN) is 80 / 100 . This indicates that analysts generally have a positive outlook on the stock.


Can you provide the analyst count for FREELINE THERAPEUTICS HOLDIN stock?

The number of analysts covering FREELINE THERAPEUTICS HOLDIN (FRLN) is 8.